These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2657051)

  • 21. Structural and developmental abnormalities of the exocrine pancreas in cystic fibrosis.
    Sturgess JM
    J Pediatr Gastroenterol Nutr; 1984; 3 Suppl 1():S55-66. PubMed ID: 6502395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound echo-intensity predicts severe pancreatic affection in cystic fibrosis patients.
    Engjom T; Erchinger F; Lærum BN; Tjora E; Gilja OH; Dimcevski G
    PLoS One; 2015; 10(3):e0121121. PubMed ID: 25803445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The exocrine pancreas in cystic fibrosis].
    Weizman Z
    Harefuah; 1986 May; 110(9):469-70. PubMed ID: 3530920
    [No Abstract]   [Full Text] [Related]  

  • 24. Cystic fibrosis serum pancreatic amylase. Useful discriminator of exocrine function.
    Gillard BK; Cox KL; Pollack PA; Geffner ME
    Am J Dis Child; 1984 Jun; 138(6):577-80. PubMed ID: 6202136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of the pancreas in cystic fibrosis.
    Durie PR
    Neth J Med; 1992 Oct; 41(3-4):97-100. PubMed ID: 1470291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of tests of exocrine and endocrine pancreatic function in older patients with cystic fibrosis.
    Lamers CB; Jansen JB; Hafkenscheid JC; Jongerius CM
    Pancreas; 1990; 5(1):65-9. PubMed ID: 1688391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pancreas in cystic fibrosis.
    Taylor CJ; Aswani N
    Paediatr Respir Rev; 2002 Mar; 3(1):77-81. PubMed ID: 12065186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of intestinal lactulose permeability with exocrine pancreatic dysfunction.
    Mack DR; Flick JA; Durie PR; Rosenstein BJ; Ellis LE; Perman JA
    J Pediatr; 1992 May; 120(5):696-701. PubMed ID: 1578303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and treatment of exocrine pancreatic insufficiency in mucoviscidosis].
    Shmerling DH
    Z Allgemeinmed; 1972 Aug; 48(24):1080-4. PubMed ID: 4649650
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of secretine sniff on exocrine pancreatic function in cystic fibrosis (author's transl)].
    Hottinger S; Biland F; Bender S; Hadorn B
    Schweiz Rundsch Med Prax; 1975 Sep; 64(38):1209-13. PubMed ID: 1178645
    [No Abstract]   [Full Text] [Related]  

  • 31. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations.
    Walkowiak J; Sands D; Nowakowska A; Piotrowski R; Zybert K; Herzig KH; Milanowski A
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):199-201. PubMed ID: 15699697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pancreas in cystic fibrosis. An update on ontogeny and physiology, on alterations of function and structure, and on the treatment of pancreatic insufficiency and malnutrition.
    J Pediatr Gastroenterol Nutr; 1984; 3 Suppl 1():S1-170. PubMed ID: 6502387
    [No Abstract]   [Full Text] [Related]  

  • 33. Longitudinal follow-up of exocrine pancreatic function in pancreatic sufficient cystic fibrosis patients using the fecal elastase-1 test.
    Walkowiak J; Nousia-Arvanitakis S; Agguridaki C; Fotoulaki M; Strzykala K; Balassopoulou A; Witt M; Herzig KH
    J Pediatr Gastroenterol Nutr; 2003 Apr; 36(4):474-8. PubMed ID: 12658038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants.
    Imrie JR; Fagan DG; Sturgess JM
    Am J Pathol; 1979 Jun; 95(3):697-708. PubMed ID: 453330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of pancreatic function by magnetic resonance in cystic fibrosis.
    Heijerman HG; Tjon a Tham RT; Bakker W; Falke TH; Lamers CB
    Neth J Med; 1993 Aug; 43(1-2):59-63. PubMed ID: 8232695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pancreas physiopathology in cystic fibrosis].
    Kashirskaia NIu; Kapranov NI; Kusova ZA; Shelepneva NE
    Eksp Klin Gastroenterol; 2010; (8):98-103. PubMed ID: 21268333
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence for a primary defect of pancreatic HCO3-secretion in cystic fibrosis.
    Gaskin KJ; Durie PR; Corey M; Wei P; Forstner GG
    Pediatr Res; 1982 Jul; 16(7):554-7. PubMed ID: 7110775
    [No Abstract]   [Full Text] [Related]  

  • 38. Pancreatic polypeptide secretion. A marker for disturbed pancreatic function in cystic fibrosis.
    Stern A; Davidson GP; Kirubakaran CP; Deutsch J; Smith A; Hansky J
    Dig Dis Sci; 1983 Oct; 28(10):870-3. PubMed ID: 6617399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: a correlation study.
    Weintraub A; Blau H; Mussaffi H; Picard E; Bentur L; Kerem E; Stankiewicz H; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2009 Mar; 48(3):306-10. PubMed ID: 19274786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis.
    Cade A; Walters MP; McGinley N; Firth J; Brownlee KG; Conway SP; Littlewood JM
    Pediatr Pulmonol; 2000 Mar; 29(3):172-6. PubMed ID: 10686036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.